CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Getinge B - GETIb CFD

    224.6
    2.9%
    1.0
    Low: 223.1
    High: 231.9
    Market Trading Hours* (UTC) Opens on Tuesday at 08:00

    Mon - Fri: 08:00 - 16:25

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 1.0
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021948 %
    Charges from full value of position ($-4.17)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021948%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000275 %
    Charges from full value of position ($-0.05)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000275%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency SEK
    Margin 5%
    Stock exchange Sweden
    Commission on trade 0%

    *Information provided by Capital.com

    Getinge AB ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 231.3
    Open* 231.2
    1-Year Change* -4.23%
    Day's Range* 223.1 - 231.9
    52 wk Range 174.20-275.20
    Average Volume (10 days) 736.17K
    Average Volume (3 months) 18.58M
    Market Cap 55.84B
    P/E Ratio 26.60
    Shares Outstanding 272.37M
    Revenue 30.42B
    EPS 8.26
    Dividend (Yield %) 1.93446
    Beta 0.87
    Next Earnings Date Feb 1, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 231.3 0.3 0.13% 231.0 233.4 227.2
    Dec 7, 2023 230.6 0.4 0.17% 230.2 232.7 229.4
    Dec 6, 2023 231.0 4.7 2.08% 226.3 232.3 226.1
    Dec 5, 2023 226.4 1.6 0.71% 224.8 228.6 224.8
    Dec 4, 2023 225.8 -0.2 -0.09% 226.0 229.0 225.1
    Dec 1, 2023 226.8 3.7 1.66% 223.1 227.4 223.1
    Nov 30, 2023 223.6 -2.1 -0.93% 225.7 226.3 221.2
    Nov 29, 2023 226.1 5.4 2.45% 220.7 226.6 220.1
    Nov 28, 2023 222.0 1.3 0.59% 220.7 223.3 220.5
    Nov 27, 2023 221.3 0.7 0.32% 220.6 223.7 220.6
    Nov 24, 2023 221.4 -0.7 -0.32% 222.1 223.4 220.5
    Nov 23, 2023 223.2 3.8 1.73% 219.4 223.8 219.3
    Nov 22, 2023 219.3 2.2 1.01% 217.1 221.4 216.7
    Nov 21, 2023 218.6 -0.9 -0.41% 219.5 222.0 217.6
    Nov 20, 2023 220.2 1.5 0.69% 218.7 221.5 218.1
    Nov 17, 2023 218.7 1.9 0.88% 216.8 220.3 215.5
    Nov 16, 2023 215.8 0.7 0.33% 215.1 216.7 213.4
    Nov 15, 2023 214.7 2.0 0.94% 212.7 215.9 212.1
    Nov 14, 2023 213.5 6.0 2.89% 207.5 213.9 207.2
    Nov 13, 2023 206.7 0.7 0.34% 206.0 207.2 204.3

    Getinge B Events

    Time (UTC) Country Event
    Thursday, February 1, 2024

    Time (UTC)

    07:00

    Country

    SE

    Event

    Q4 2023 Getinge AB Earnings Release
    Q4 2023 Getinge AB Earnings Release

    Forecast

    -

    Previous

    -
    Monday, April 22, 2024

    Time (UTC)

    06:00

    Country

    SE

    Event

    Q1 2024 Getinge AB Earnings Release
    Q1 2024 Getinge AB Earnings Release

    Forecast

    -

    Previous

    -

    Time (UTC)

    10:59

    Country

    SE

    Event

    Getinge AB Annual Shareholders Meeting
    Getinge AB Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 28292 27049 29819 26559 24172
    Revenue 28292 27049 29819 26559 24172
    Cost of Revenue, Total 14882 13469 15097 14104 13119
    Gross Profit 13410 13580 14722 12455 11053
    Total Operating Expense 24666 22678 25035 24187 24456
    Selling/General/Admin. Expenses, Total 7484 6972 7596 7681 7312
    Research & Development 1013 804 770 688 662
    Depreciation / Amortization 1074 1002 1450 1247 1009
    Unusual Expense (Income) 235 96 177 324 0
    Other Operating Expenses, Total -44 335 -55 143 2354
    Operating Income 3626 4371 4784 2372 -284
    Interest Income (Expense), Net Non-Operating -131 -142 -257 -408 -309
    Other, Net -23 -41 -42 -55 -31
    Net Income Before Taxes 3472 4188 4485 1909 -624
    Net Income After Taxes 2516 3001 3272 1256 -1132
    Minority Interest -25 -31 -34 -34 -28
    Net Income Before Extra. Items 2491 2970 3238 1222 -1160
    Total Extraordinary Items 193
    Net Income 2491 2970 3238 1222 -967
    Income Available to Common Excl. Extra. Items 2491 2970 3239 1222 -1160
    Income Available to Common Incl. Extra. Items 2491 2970 3239 1222 -967
    Diluted Net Income 2491 2970 3239 1222 -967
    Diluted Weighted Average Shares 272.37 272.37 272.37 272.37 272.37
    Diluted EPS Excluding Extraordinary Items 9.14565 10.9043 11.8919 4.48655 -4.25892
    Dividends per Share - Common Stock Primary Issue 4.25 4 3 1.5 1
    Diluted Normalized EPS 11.5242 13.6509 14.5142 5.66778 -3.9797
    Total Adjustments to Net Income 0 1
    Interest Expense (Income) - Net Operating 22
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total revenue 7607 7176 7141 8499 6941
    Revenue 7607 7176 7141 8499 6941
    Cost of Revenue, Total 4016 4077 3622 4671 3561
    Gross Profit 3591 3099 3519 3828 3380
    Total Operating Expense 6292 6793 6240 7671 5834
    Selling/General/Admin. Expenses, Total 2115 2140 2061 2013 1865
    Research & Development 266 256 282 275 242
    Depreciation / Amortization 253 245 245 367 245
    Unusual Expense (Income) 108 60 20 202 14
    Other Operating Expenses, Total -466 15 10 143 -93
    Operating Income 1315 383 901 828 1107
    Interest Income (Expense), Net Non-Operating -88 -78 -75 -47 -31
    Other, Net -1
    Net Income Before Taxes 1227 305 826 781 1075
    Net Income After Taxes 901 217 593 561 805
    Minority Interest -7 -2 -7 -5 -7
    Net Income Before Extra. Items 894 215 586 556 798
    Net Income 894 215 586 556 798
    Income Available to Common Excl. Extra. Items 894 214 586 556 798
    Income Available to Common Incl. Extra. Items 894 214 586 556 798
    Diluted Net Income 894 214 586 556 798
    Diluted Weighted Average Shares 272.37 272.37 272.37 272.37 272.37
    Diluted EPS Excluding Extraordinary Items 3.2823 0.7857 2.15149 2.04134 2.92984
    Dividends per Share - Common Stock Primary Issue 0 0 0 4.25 0
    Diluted Normalized EPS 2.62447 0.95549 2.21211 3.178 2.96833
    Total Adjustments to Net Income -1
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 19106 15069 17431 14494 14148
    Cash and Short Term Investments 5747 4078 6079 1266 1290
    Cash & Equivalents 5676 4076 6056 1254 1273
    Short Term Investments 71 2 23 12 17
    Total Receivables, Net 6703 5941 6606 8212 7988
    Accounts Receivable - Trade, Net 5954 5209 5854 7317 6969
    Total Inventory 6232 4767 4513 4691 4544
    Prepaid Expenses 423 283 233 325 326
    Total Assets 52032 44555 45014 44713 43352
    Property/Plant/Equipment, Total - Net 4868 4120 3973 4087 3160
    Property/Plant/Equipment, Total - Gross 12079 10493 9274 9446 8223
    Accumulated Depreciation, Total -7212 -6372 -5303 -5359 -5063
    Goodwill, Net 22512 19681 17427 18674 18092
    Intangibles, Net 4498 4467 4658 5609 6006
    Long Term Investments 0 2 15 0
    Note Receivable - Long Term 50 52 50 32 80
    Other Long Term Assets, Total 998 1166 1473 1802 1866
    Total Current Liabilities 11993 10610 9788 9864 10005
    Accounts Payable 2252 1921 1446 1995 1868
    Accrued Expenses 2348 2608 2699 2130 1960
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 793 811 2519 2952 3451
    Other Current Liabilities, Total 6600 5270 3124 2787 2726
    Total Liabilities 21994 19805 23990 24217 24151
    Total Long Term Debt 5031 3495 7687 7068 7378
    Long Term Debt 4100 2795 7020 6487 7378
    Deferred Income Tax 1150 897 829 661 693
    Minority Interest 415 427 462 477 454
    Other Liabilities, Total 3405 4376 5224 6147 5621
    Total Equity 30038 24750 21024 20496 19201
    Common Stock 136 136 136 136 136
    Additional Paid-In Capital 6789 6789 6789 6789 6789
    Retained Earnings (Accumulated Deficit) 23113 17824 14099 13571 12276
    Total Liabilities & Shareholders’ Equity 52032 44555 45014 44713 43352
    Total Common Shares Outstanding 272.37 272.37 272.37 272.37 272.37
    Capital Lease Obligations 931 700 667 581
    Other Equity, Total 1
    Other Current Assets, Total 1
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 19394 18390 17909 19106 17671
    Cash and Short Term Investments 5337 4434 4625 5676 4839
    Cash & Equivalents 5337 4434 4625 5676 4839
    Total Receivables, Net 6820 6731 6497 7198 6366
    Accounts Receivable - Trade, Net 4510 4537 4599 5275 4435
    Total Inventory 7237 7225 6787 6232 6466
    Total Assets 53540 52841 50985 52032 51907
    Property/Plant/Equipment, Total - Net 5076 5176 4954 4868 4790
    Intangibles, Net 27962 28259 27069 27010 28327
    Long Term Investments 79 75 59 1048 1119
    Total Current Liabilities 12342 11457 10388 11993 7821
    Accounts Payable 2142 2139 2098 2252 1902
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 2276 1468 868 793
    Other Current Liabilities, Total 7924 7850 7422 8948 5919
    Total Liabilities 21811 21833 20352 21994 21455
    Total Long Term Debt 4538 5426 4948 5031 5499
    Long Term Debt 3548 4390 3937 4100 4209
    Capital Lease Obligations 990 1036 1011 931 1290
    Minority Interest 287 296 426 415 455
    Other Liabilities, Total 3206 3468 3369 3405 7680
    Total Equity 31729 31008 30633 30038 30452
    Common Stock 136 136 136 136 136
    Additional Paid-In Capital 6789 6789 6789 6789 6789
    Retained Earnings (Accumulated Deficit) 24804 24083 23707 23113 23527
    Total Liabilities & Shareholders’ Equity 53540 52841 50985 52032 51907
    Total Common Shares Outstanding 272.37 272.37 272.37 272.37 272.37
    Other Long Term Assets, Total 1029 941 994
    Deferred Income Tax 1438 1186 1221 1150
    Other Equity, Total 1 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 3626 4371 4784 2372 -284
    Cash From Operating Activities 3367 6560 7199 3832 2503
    Cash From Operating Activities 2027 1814 2467 2223 1808
    Non-Cash Items -31 126 -86 -121 1866
    Cash Taxes Paid 1012 693 553 357 366
    Cash Interest Paid
    Changes in Working Capital -2255 249 34 -642 -887
    Cash From Investing Activities -1470 -1329 -1991 -1117 -1339
    Capital Expenditures -1136 -930 -1045 -1220 -1380
    Other Investing Cash Flow Items, Total -334 -399 -946 103 41
    Cash From Financing Activities -500 -7237 -297 -2772 -1440
    Financing Cash Flow Items -16 -1 -17 3 -11
    Total Cash Dividends Paid -1090 -858 -433 -298 -424
    Issuance (Retirement) of Stock, Net 0
    Issuance (Retirement) of Debt, Net 606 -6378 153 -2477 -1005
    Foreign Exchange Effects 203 26 -110 38 23
    Net Change in Cash 1600 -1980 4801 -19 -253
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 901 3626 2798 1691 780
    Cash From Operating Activities -427 3367 2346 1070 647
    Cash From Operating Activities 460 2027 1332 875 438
    Non-Cash Items -116 -31 -161 -105 -58
    Cash Taxes Paid 179 1012 711 578 268
    Changes in Working Capital -1672 -2255 -1623 -1391 -513
    Cash From Investing Activities -441 -1470 -1088 -551 -262
    Capital Expenditures -291 -1136 -815 -539 -239
    Other Investing Cash Flow Items, Total -150 -334 -273 -12 -23
    Cash From Financing Activities -226 -500 -749 -604 -219
    Financing Cash Flow Items -9 -16 -20 -1 -1
    Total Cash Dividends Paid 0 -1090 -1089 -1089 0
    Issuance (Retirement) of Debt, Net -217 606 360 486 -218
    Foreign Exchange Effects 43 203 255 156 78
    Net Change in Cash -1051 1600 764 71 244
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Bennet (Carl) Individual Investor 14.2957 36332969 -115465 2023-07-31 LOW
    Fjärde AP-Fonden Pension Fund 8.2076 20859926 -60258 2023-07-31 LOW
    AMF Tjänstepension AB Pension Fund 5.3358 13561142 -90000 2023-08-29 LOW
    Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 4.1272 10489417 -112699 2023-09-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.1996 8131955 208996 2023-07-31 LOW
    Didner & Gerge Fonder AB Investment Advisor 2.9673 7541375 -1816866 2023-07-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 2.9568 7514786 52957 2023-07-31 LOW
    Incentive AS Investment Advisor/Hedge Fund 2.8891 7342623 290008 2023-07-31 LOW
    Aviva Investors Global Services Limited Investment Advisor/Hedge Fund 2.6 6608038 5777565 2023-08-31 LOW
    Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 2.5639 6516317 -1556103 2023-07-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.1717 5519548 0 2023-07-31 LOW
    Carnegie Fonder AB Bank and Trust 2.165 5502395 1087405 2023-07-31 LOW
    Folksam Group Insurance Company 1.9034 4837530 319711 2023-07-31 LOW
    Lansförsäkringar Fondförvaltning AB Investment Advisor 1.2544 3188028 29615 2023-07-31 LOW
    Marathon-London Investment Advisor 1.2049 3062308 0 2023-07-31 LOW
    Storebrand Kapitalforvaltning AS Investment Advisor 1.0874 2763569 -107812 2023-09-30 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.9228 2345198 -3421 2023-09-30 LOW
    Lannebo Fonder AB Investment Advisor/Hedge Fund 0.8361 2125000 565000 2023-07-31 LOW
    E.Öhman J:or Fonder AB Investment Advisor 0.8358 2124167 724410 2023-07-31 LOW
    Cliens Asset Management AB Investment Advisor 0.7968 2025000 -710000 2023-07-31 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Getinge Company profile

    About Getinge AB

    Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, GetingeAB revenues decreased 9% to SEK27.05B. Net incomeapplicable to common stockholders decreased 8% to SEK2.97B.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Net income also reflects Research & Development Expenditure, Cap decrease of 19% to SEK346M (income), Acquisitionexpenses increase from SEK8M to SEK35M (expense).

    Equity composition

    April 2001: Bonus Issue, adjustment factor 0.9717.November 2003: Stock Split in the ratio 1:4. 02/2008,Rights Issue, 1 new share for every 16 shares held @ SEK120 (Factor: 1.014783). 11/2008, Rights Issue, 1 new sharefor every 9 shares held @ SEK 83.5 (Factor: 1.01930).

    Industry: Medical Equipment

    Lindholmspiren 7
    P.O. Box 8861
    GOETEBORG
    VASTRA GOTALANDS 417 56
    SE

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Oil - Crude

    71.59 Price
    +0.260% 1D Chg, %
    Long position overnight fee -0.0212%
    Short position overnight fee -0.0007%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.63 Price
    -6.340% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    BTC/USD

    41,319.65 Price
    -5.690% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,231.80 Price
    +0.940% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading